Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review

Severe Acute Respiratory Syndrome related to Coronavirus-2 (SARS-CoV-2), coronavirus disease-2019 (COVID-19) may cause severe illness in 20% of patients. This may be in part due to an uncontrolled immune-response to SARS-CoV-2 infection triggering a systemic hyperinflammatory response, the so-called...

Descripción completa

Detalles Bibliográficos
Autores principales: Alijotas-Reig, Jaume, Esteve-Valverde, Enrique, Belizna, Cristina, Selva-O'Callaghan, Albert, Pardos-Gea, Josep, Quintana, Angela, Mekinian, Arsene, Anunciacion-Llunell, Ariadna, Miró-Mur, Francesc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252146/
https://www.ncbi.nlm.nih.gov/pubmed/32376394
http://dx.doi.org/10.1016/j.autrev.2020.102569

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252146/
https://www.ncbi.nlm.nih.gov/pubmed/32376394
http://dx.doi.org/10.1016/j.autrev.2020.102569

Ejemplares similares